Live Breaking News & Updates on Harma Ipo

Stay updated with breaking news from Harma ipo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glenmark arm, Emcure, 3 other pharma companies line up Rs 7,000-crore IPOs

Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Pharma and CX Partners-funded Veeda Clinical Research. According to investment-bankers, they are planning to mop up over Rs 7,000 crore in primary share sales. ....

United Kingdom , Supriya Lifesciences , Satish Mehta , Glenmark Lifesciences , Emcure Pharma , Satish Waman Wagh , Ajanta Pharma , Deepak Jasani , Aurobindo Pharma , Vinod Nair , Veeda Clinical Research , Bain Emcure Pharmaceuticals , Cx Veeda Clinical Research , Glenmark Pharmaceuticals , Geojit Financial Services , Windlass Biotech , Bain Capital Backed Emcure Pharma , Veeda Clinical , Arti Pharama , Ipca Labs , Gland Pharma , China Plus One , Bain Capital Backed Emcure Pharmaceuticals , Satish Waman , Initial Public Offering , Harma Ipo ,